TY - JOUR T1 - Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report JF - Breathe JO - Breathe DO - 10.1183/20734735.0058-2020 VL - 16 IS - 2 SP - 200058 AU - Sandhya Khurana AU - Andrew Bush AU - Fernando Holguin A2 - , Y1 - 2020/06/01 UR - http://breathe.ersjournals.com/content/16/2/200058.abstract N2 - Educational aimsThis article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists.It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.This article summarises the 2019 @EuroRespSoc/@ATScommunity Severe Asthma Task Force recommendations on the use of anti-IL-5 strategy, anti-IL-4/13 antibody, tiotropium and macrolides in severe asthma, and the role of biomarkers in directing therapy https://bit.ly/3braK43 ER -